Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |